Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
Authors
Keywords
-
Journal
Brain Behavior Immunity Health
Volume 27, Issue -, Pages 100585
Publisher
Elsevier BV
Online
2022-12-31
DOI
10.1016/j.bbih.2022.100585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
- (2021) Maria Antonietta Nettis et al. NEUROPSYCHOPHARMACOLOGY
- No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
- (2021) Bernhard T. Baune et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Depression heterogeneity and its biological underpinnings: towards immuno-metabolic depression
- (2020) Yuri Milaneschi et al. BIOLOGICAL PSYCHIATRY
- Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial
- (2020) Christian Otte et al. BMJ Open
- Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
- (2019) O. Köhler‐Forsberg et al. ACTA PSYCHIATRICA SCANDINAVICA
- Psychometric properties of 12-item self-administered World Health Organization disability assessment schedule 2.0 (WHODAS 2.0) among general population and people with non-acute physical causes of disability – systematic review
- (2019) Mikhail Saltychev et al. DISABILITY AND REHABILITATION
- Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
- (2019) Emanuele Felice Osimo et al. PSYCHOLOGICAL MEDICINE
- Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium
- (2019) Gara Arteaga-Henríquez et al. Frontiers in Psychiatry
- Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
- (2019) Gayle M. Wittenberg et al. MOLECULAR PSYCHIATRY
- Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states
- (2018) W. Kyle Simmons et al. MOLECULAR PSYCHIATRY
- Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
- (2018) Célia Fourrier et al. Trials
- Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation
- (2018) Golam M Khandaker et al. BMJ Open
- Cardiovascular safety of celecoxib, naproxen and ibuprofen
- (2017) Michael T. Nurmohamed Nature Reviews Rheumatology
- Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis
- (2017) Andrea Cipriani et al. PSYCHOLOGICAL MEDICINE
- Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
- (2016) N Kappelmann et al. MOLECULAR PSYCHIATRY
- Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users
- (2014) Nicole Vogelzangs et al. NEUROPSYCHOPHARMACOLOGY
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications
- (2013) J.C. Felger et al. NEUROSCIENCE
- Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
- (2012) F Lamers et al. MOLECULAR PSYCHIATRY
- Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
- (2011) A. John Rush et al. AMERICAN JOURNAL OF PSYCHIATRY
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF
- (2011) Gillian A. Hawker et al. ARTHRITIS CARE & RESEARCH
- Adverse reactions to antidepressants
- (2009) Rudolf Uher et al. BRITISH JOURNAL OF PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now